209 related articles for article (PubMed ID: 17310017)
1. Clinical evidence of an intermolecular epitope spreading in a patient with pemphigus foliaceus converting into bullous pemphigoid.
Peterson JD; Chang AJ; Chan LS
Arch Dermatol; 2007 Feb; 143(2):272-4. PubMed ID: 17310017
[No Abstract] [Full Text] [Related]
2. Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.
Recke A; Rose C; Schmidt E; Bröcker EB; Zillikens D; Sitaru C
J Am Acad Dermatol; 2009 Aug; 61(2):333-6. PubMed ID: 19615544
[TBL] [Abstract][Full Text] [Related]
3. Transition from Bullous Pemphigoid to Pemphigus Foliaceus: Intermolecular Epitope Spreading Thirteen Years after Initial Diagnosis.
Schauer F; Steinke H; Thoma K; Kiritsi D
Acta Derm Venereol; 2019 Oct; 99(11):1029-1030. PubMed ID: 31282977
[No Abstract] [Full Text] [Related]
4. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
[TBL] [Abstract][Full Text] [Related]
5. Combined features of pemphigus foliaceus and bullous pemphigoid: immunoblot and immunoelectron microscopic studies.
Ishiko A; Hashimoto T; Shimizu H; Masunaga T; Nishibori Y; Watanabe K; Nishikawa T
Arch Dermatol; 1995 Jun; 131(6):732-4. PubMed ID: 7778933
[No Abstract] [Full Text] [Related]
6. Coexistence of pemphigus and bullous pemphigoid.
Leibovici V; Ron N; Goldenhersh M; Holubar K
Int J Dermatol; 1989 May; 28(4):259-60. PubMed ID: 2656552
[No Abstract] [Full Text] [Related]
7. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.
Budimir J; Mihić LL; Situm M; Bulat V; Persić S; Tomljanović-Veselski M
Acta Clin Croat; 2008 Mar; 47(1):13-8. PubMed ID: 18714642
[TBL] [Abstract][Full Text] [Related]
8. Pemphigus foliaceus progressing to bullous pemphigoid.
Iwakura R; Oiso N; Tateishi C; Suzuki M; Uchida S; Yanagihara S; Hashimoto T; Tsuruta D; Kawada A
J Dermatol; 2019 Nov; 46(11):e424-e426. PubMed ID: 31342555
[No Abstract] [Full Text] [Related]
9. Coexistence of pemphigus vulgaris and bullous pemphigoid in the upper aerodigestive tract.
Tabuchi K; Nomura M; Murashita H; Fujisawa Y; Tsuji S; Okubo H; Hara A
Auris Nasus Larynx; 2006 Jun; 33(2):231-3. PubMed ID: 16168587
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.
Hammers CM; Stanley JR
Annu Rev Pathol; 2016 May; 11():175-97. PubMed ID: 26907530
[TBL] [Abstract][Full Text] [Related]
11. Development of pemphigus foliaceus in a patient with psoriasis: a simple coincidence?
Tomasini D; Cerri A; Cozzani E; Berti E
Eur J Dermatol; 1998; 8(1):56-9. PubMed ID: 9649683
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of paraneoplastic pemphigus and bullous pemphigoid.
Kakurai M; Demitsu T; Iida E; Umemoto N; Yamada T; Yoneda K; Kako S; Ohshima K; Ohyama B; Hashimoto T
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):962-4. PubMed ID: 19207671
[No Abstract] [Full Text] [Related]
13. Pemphigus and pemphigoid in dog and man: comparative aspects.
Scott DW; Lewis RM
J Am Acad Dermatol; 1981 Aug; 5(2):148-67. PubMed ID: 6790583
[TBL] [Abstract][Full Text] [Related]
14. The immunopathology of pemphigus and bullous pemphigoid. 1968.
Beutner EH; Jordon RE; Chorzelski TP
J Invest Dermatol; 1989 Apr; 92(4 Suppl):166S; discussion 167S-168S. PubMed ID: 2649608
[No Abstract] [Full Text] [Related]
15. Detection and characterization of anti-envoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay.
Mouquet H; Drenovska K; Lartigue A; Joly P; Drouot L; Thomas M; Tron F; Gilbert D
Clin Immunol; 2008 Nov; 129(2):304-12. PubMed ID: 18790674
[TBL] [Abstract][Full Text] [Related]
16. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion.
Stanley JR
Adv Immunol; 1993; 53():291-325. PubMed ID: 8512037
[No Abstract] [Full Text] [Related]
17. Clinical Relevance of Polymorphonuclear Myeloid-Derived Suppressor Cells in Autoimmune-Blistering Disorders Pemphigus Vulgaris and Bullous Pemphigoid.
Oktem A; Horzum U; Ertop P; Kundakci N; Akay BN; Yalcin B; Esendagli G
J Invest Dermatol; 2021 Mar; 141(3):672-675.e1. PubMed ID: 32791069
[No Abstract] [Full Text] [Related]
18. Concurrence of bullous pemphigoid and herpetiform pemphigus with IgG antibodies to desmogleins 1/3 and desmocollins 1-3.
Ohata C; Koga H; Teye K; Ishii N; Hamada T; Dainichi T; Furumura M; Sato M; Sueki H; Hashimoto T
Br J Dermatol; 2013 Apr; 168(4):879-81. PubMed ID: 22924466
[No Abstract] [Full Text] [Related]
19. The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan.
Ogawa H; Sakuma M; Morioka S; Kitamura K; Sasai Y; Imamura S; Inaba Y
J Dermatol Sci; 1995 Mar; 9(2):136-41. PubMed ID: 7772576
[TBL] [Abstract][Full Text] [Related]
20. The incidence of internal malignancies in autoimmune bullous diseases.
Iwashita K; Matsuyama T; Akasaka E; Mizutani K; Yamamoto K; Kondoh A; Nozawa M; Yagi Y; Ikoma N; Mabuchi T; Shinagawa H; Tamiya S; Nuruki H; Ohta Y; Umezawa Y; Ozawa A
Tokai J Exp Clin Med; 2007 Mar; 32(1):42-7. PubMed ID: 21319056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
